David G. Maloney

1 ta ish

Fred Hutch Cancer Center

1. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

   Jeremy S Abramson, M. Lia Palomba, Leo I. Gordon +19

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.296869